Biogen Idec, Inc. (Massachusetts) (JOBS), Elan Corporation PLC (JOBS) Shares Plummet on New Tysabri Review

Reuters -- European regulators said they have begun a review of the multiple sclerosis drug Tysabri following reports of 23 cases of a potentially deadly brain infection.